{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:28:59Z","timestamp":1788838139672,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd004760.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000}}],"reference-count":93,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004760.pub4","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T05:50:04Z","timestamp":1378965004000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Creatine for treating muscle disorders"],"prefix":"10.1002","volume":"2013","author":[{"given":"Rudolf A","family":"Kley","sequence":"first","affiliation":[{"name":"University Hospital Bergmannsheil, Ruhr University Bochum; Department of Neurology; Buerkle-de-la-Camp-Platz 1 Bochum Germany 44789"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Tarnopolsky","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Neurology and Rehabilitation; 1200 Main Street West Hamilton Ontario Canada L8N 3Z5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Vorgerd","sequence":"additional","affiliation":[{"name":"Kliniken Bergmannsheil, Ruhr University Bochum; Department of Neurology; Buerkle-de-la-Camp-Platz 1 Bochum Germany 44789"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.mri.2010.03.008","article-title":"Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study","volume":"28","author":"Banerjee","year":"2010","journal-title":"Magnetic Resonance Imaging"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.22687","article-title":"Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial","volume":"57","author":"Chung","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ana.20523","article-title":"CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy","volume":"58","author":"Escolar","year":"2005","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD004760.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1212\/WNL.55.11.1748","article-title":"A placebo-controlled crossover trial of creatine in mitochondrial diseases","volume":"55","author":"Klopstock","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1468-1331.2004.00970.x","article-title":"Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS cross-over study","volume":"12","author":"Kornblum","year":"2005","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mus.10355","article-title":"Beneficial effects of creatine supplementation in dystrophic patients","volume":"27","author":"Louis","year":"2003","journal-title":"Muscle and Nerve"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.WNL.0000044405.29988.E1","article-title":"Creatine monohydrate in DM2\/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy","volume":"60","author":"Schneider-Gold","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD004760.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle and Nerve"},{"issue":"10","key":"10.1002\/14651858.CD004760.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/01.WNL.0000125178.18862.9D","article-title":"Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy","volume":"62","author":"Tarnopolsky","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mus.10527","article-title":"Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1","volume":"29","author":"Tarnopolsky","year":"2004","journal-title":"Muscle and Nerve"},{"issue":"7","key":"10.1002\/14651858.CD004760.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archneur.57.7.956","article-title":"Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled cross-over trial","volume":"57","author":"Vorgerd","year":"2000","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.59.1.97","article-title":"Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled cross-over study","volume":"59","author":"Vorgerd","year":"2002","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD004760.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.54.9.1848","article-title":"Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study","volume":"54","author":"Walter","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD004760.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00415-002-0923-x","article-title":"Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study","volume":"249","author":"Walter","year":"2002","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2002-33679","article-title":"Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy","volume":"33","author":"Barisic","year":"2002","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0016|cit16","first-page":"276","article-title":"Trial therapy of acute polymyositis with phosphocreatine.","volume":"74","author":"Beurey","year":"1967","journal-title":"Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie"},{"issue":"9","key":"10.1002\/14651858.CD004760.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/(SICI)1097-4598(199909)22:9<1299::AID-MUS24>3.0.CO;2-4","article-title":"Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies","volume":"22","author":"Borchert","year":"1999","journal-title":"Muscle and Nerve"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0018|cit18","first-page":"208","article-title":"Dermatomyositis with cardiac involvement and trial treatment with phosphocreatine","volume":"79","author":"Duperrat","year":"1972","journal-title":"Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/01616412.2000.11741051","article-title":"Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study","volume":"22","author":"Felber","year":"2000","journal-title":"Neurological Research"},{"issue":"8131","key":"10.1002\/14651858.CD004760.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0140-6736(79)92031-2","article-title":"Phosphocreatinine in myotonic dystrophy (Steinert\u00b4s disease)","volume":"1","author":"Freddi","year":"1979","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD004760.pub4-BIB0021|cit21","first-page":"1236","article-title":"Creatine treatment in MELAS","volume":"17","author":"Hagenfeldt","year":"1994","journal-title":"Muscle and Nerve"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0887-8994(02)00469-1","article-title":"Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies","volume":"28","author":"Komura","year":"2003","journal-title":"Pediatric Neurology"},{"issue":"10","key":"10.1002\/14651858.CD004760.pub4-BIB0023|cit23","first-page":"661","article-title":"A clinical trial of creatine monohydrate in muscular dystrophy patients","volume":"44","author":"Matusmura","year":"2004","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Muscle and Nerve"},{"key":"10.1002\/14651858.CD004760.pub4-BIB0025|cit25","first-page":"375","article-title":"Lack of detectable effect of creatine supplementation on skeletal muscle or cardiac function in Duchenne muscular dystrophy","volume":"10","author":"Sejersen","year":"2000","journal-title":"Neuromuscular Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004760.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00005768-200106000-00003","article-title":"Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study","volume":"33","author":"Stout","year":"2001","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.52.4.854","article-title":"Creatine monohydrate increases strength in patients with neuromuscular disease","volume":"52","author":"Tarnopolsky","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mus.20020","article-title":"Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation","volume":"29","author":"Tarnopolsky","year":"2004","journal-title":"Muscle and Nerve"},{"key":"10.1002\/14651858.CD004760.pub4-BIB0029|cit29","unstructured":"NCT01217320 Creatine supplementation in pediatric rheumatology http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01217320"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0031|cit31","first-page":"11","article-title":"Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults","volume":"58","author":"Brose","year":"2003","journal-title":"Journals of Gerontology. Series B, Psychological Sciences and Social Sciences"},{"issue":"11","key":"10.1002\/14651858.CD004760.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1249\/01.MSS.0000093614.17517.79","article-title":"Effect of creatine and weight training on muscle creatine and performance in vegetarians","volume":"35","author":"Burke","year":"2003","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD004760.pub4-BIB0033|cit33","first-page":"E31","article-title":"Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans","volume":"271","author":"Casey","year":"1996","journal-title":"American Journal of Physiology"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mus.20078","article-title":"Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease","volume":"30","author":"Chetlin","year":"2004","journal-title":"Muscle and Nerve"},{"issue":"10","key":"10.1002\/14651858.CD004760.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1249\/01.MSS.0000142301.70419.C6","article-title":"Effect of creatine ingestion after exercise on muscle thickness in males and females","volume":"36","author":"Chilibeck","year":"2004","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0036|cit36","first-page":"352","article-title":"Creatine monohydrate and resistance training increase bone mineral content and density in older men","volume":"9","author":"Chilibeck","year":"2005","journal-title":"Journal of Nutrition, Health and Aging"},{"issue":"12","key":"10.1002\/14651858.CD004760.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1097\/00005768-200112000-00021","article-title":"Creatine supplementation combined with resistance training in older men","volume":"33","author":"Chrusch","year":"2001","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD004760.pub4-BIB0038|cit38","first-page":"R698","article-title":"Increase of total creatine in human brain after oral supplementation of creatine-monohydrate","volume":"277","author":"Dechent","year":"1999","journal-title":"American Journal of Physiology"},{"issue":"6","key":"10.1002\/14651858.CD004760.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/japplphysiol.00873.2007","article-title":"Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle","volume":"104","author":"Deldicque","year":"2008","journal-title":"Journal of Applied Physiology"},{"issue":"8","key":"10.1002\/14651858.CD004760.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.56.8.1075","article-title":"A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy","volume":"56","author":"Fenichel","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD004760.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"1-2","key":"10.1002\/14651858.CD004760.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1022413202549","article-title":"Creatine supplementation during college football training does not increase the incidence of cramping or injury","volume":"244","author":"Greenwood","year":"2003","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-2004-817917","article-title":"Few adverse effects of long-term creatine supplementation in a placebo-controlled trial","volume":"26","author":"Groeneveld","year":"2005","journal-title":"International Journal of Sports Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00726-009-0263-6","article-title":"Exploring the therapeutic role of creatine supplementation","volume":"38","author":"Gualano","year":"2010","journal-title":"Amino Acids"},{"issue":"12","key":"10.1002\/14651858.CD004760.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1016\/S0021-9258(18)52891-X","article-title":"A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression","volume":"268","author":"Guimbal","year":"1993","journal-title":"Journal of Biological Chemistry"},{"issue":"26","key":"10.1002\/14651858.CD004760.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"17556","DOI":"10.1016\/S0021-9258(17)32477-8","article-title":"Cloning and sequencing of rat kidney L-arginine: glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine","volume":"269","author":"Guthmiller","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/cs0830367","article-title":"Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation","volume":"83","author":"Harris","year":"1992","journal-title":"Clinical Science"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004760.pub4-BIB0050|cit50","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1152\/jappl.1996.81.1.232","article-title":"Muscle creatine loading in men","volume":"81","author":"Hultman","year":"1996","journal-title":"Journal of Applied Physiology"},{"issue":"8","key":"10.1002\/14651858.CD004760.pub4-BIB0052|cit52","first-page":"1380","article-title":"A functional index in myositis","volume":"23","author":"Josefson","year":"1996","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2003.12.014","article-title":"Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase","volume":"15","author":"Klivenyi","year":"2004","journal-title":"Neurobiology of Disease"},{"issue":"1-2","key":"10.1002\/14651858.CD004760.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1022469320296","article-title":"Long-term creatine supplementation does not significantly affect clinical markers of health in athletes","volume":"244","author":"Kreider","year":"2003","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1-2","key":"10.1002\/14651858.CD004760.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(00)02038-2","article-title":"Neuroprotective effects of creatine administration against NMDA and malonate toxicity","volume":"860","author":"Malcon","year":"2000","journal-title":"Brain Research"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003725.pub3","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD004760.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ana.410280620","article-title":"Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies","volume":"28","author":"Matthews","year":"1990","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.41.1.114","article-title":"In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease","volume":"41","author":"Matthews","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington\u00b4s disease","volume":"18","author":"Matthews","year":"1998","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005768-200002000-00007","article-title":"Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women","volume":"32","author":"Mihic","year":"2000","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1152\/jappl.2001.91.3.1041","article-title":"Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis","volume":"91","author":"Parise","year":"2001","journal-title":"Journal of Applied Physiology"},{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/art.1780370519","article-title":"Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis","volume":"37","author":"Park","year":"1994","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780380111","article-title":"Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis","volume":"38","author":"Park","year":"1995","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0960-8966(01)00273-5","article-title":"Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice","volume":"12","author":"Passaquin","year":"2002","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0091270002239703","article-title":"Single- and multiple-dose pharmacokinetics of oral creatine","volume":"43","author":"Persky","year":"2003","journal-title":"Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD004760.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/00005768-199908000-00005","article-title":"Long-term oral creatine supplementation does not impair renal function in healthy athletes","volume":"31","author":"Poortmans","year":"1999","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00007256-200030030-00002","article-title":"Adverse effects of creatine supplementation: fact or fiction?","volume":"30","author":"Poortmans","year":"2000","journal-title":"Sports Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004760.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1249\/01.mss.0000176398.64189.e6","article-title":"Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate","volume":"37","author":"Poortmans","year":"2005","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(98)01399-4","article-title":"Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells","volume":"439","author":"Pulido","year":"1998","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0071|cit71","first-page":"162","article-title":"Effects of repeated creatine supplementation on muscle, plasma, and urine creatine levels","volume":"18","author":"Rawson","year":"2004","journal-title":"Journal of Strength and Conditioning Research"},{"key":"10.1002\/14651858.CD004760.pub4-BIB0072|cit72","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002276.pub2","article-title":"Drug treatment for facioscapulohumeral muscular dystrophy","author":"Rose","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD004760.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1139\/y02-129","article-title":"Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats","volume":"80","author":"Roy","year":"2002","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD004760.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1152\/physiolgenomics.00157.2007","article-title":"Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation","volume":"32","author":"Safdar","year":"2008","journal-title":"Physiological Genomics"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.880050405","article-title":"Quantitation of muscle function in children: a prospective study in duchenne muscular dystrophy","volume":"5","author":"Scott","year":"1982","journal-title":"Muscle and Nerve"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yrtph.2006.05.005","article-title":"Risk assessment for creatine monohydrate","volume":"45","author":"Shao","year":"2006","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD004760.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","article-title":"A clinical trial of creatine in ALS","volume":"63","author":"Shefner","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.43.5.876","article-title":"Treatment of inclusion-body myositis with high-dose intravenous immunglobulin","volume":"43","author":"Soueidan","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W","article-title":"Dietary supplement creatine protects against traumatic brain injury","volume":"48","author":"Sullivan","year":"2000","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD004760.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.0.CO;2-6","article-title":"Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease","volume":"22","author":"Tarnopolsky","year":"1999","journal-title":"Muscle and Nerve"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.52.4.854","article-title":"Creatine monohydrate increases strength in patients with neuromuscular disease","volume":"52","author":"Tarnopolsky","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1123\/ijsnem.10.4.452","article-title":"Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females","volume":"10","author":"Tarnopolsky","year":"2000","journal-title":"International Journal of Sport Nutrition and Exercise Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD004760.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/mus.1055","article-title":"Creatine transporter and mitochondrial creatine kinase protein content in myopathies","volume":"24","author":"Tarnopolsky","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/00005768-200003000-00024","article-title":"American College of Sports Medicine round table. The physiological and health effects of oral creatine supplementation","volume":"32","author":"Terjung","year":"2000","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"7","key":"10.1002\/14651858.CD004760.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000090629.40891.4B","article-title":"Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial","volume":"61","author":"Verbessem","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0005-2728(92)90096-K","article-title":"Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism","volume":"1102","author":"Wyss","year":"1992","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1002\/14651858.CD004760.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0306-9877(98)90058-5","article-title":"The therapeutic potential of oral creatine supplementation in muscle disease","volume":"51","author":"Wyss","year":"1998","journal-title":"Medical Hypotheses"},{"issue":"3","key":"10.1002\/14651858.CD004760.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiological Reviews"},{"issue":"26","key":"10.1002\/14651858.CD004760.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1523\/JNEUROSCI.1278-04.2004","article-title":"Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice","volume":"24","author":"Zhu","year":"2004","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004760","article-title":"Creatine for treating muscle disorders","author":"Kley","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004760.pub4-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004760.pub2","article-title":"Creatine for treating muscle disorders","author":"Kley","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004760.pub4-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004760.pub3","article-title":"Creatine for treating muscle disorders","author":"Kley","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004760.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:32:32Z","timestamp":1775115152000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004760.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":93,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004760.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,5]]}}}